GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arqule, Inc. (ARQL) [hlAlert]

Rating:
Accumulate
ARQL
down 73.65 %

Arqule, Inc. (ARQL) rated Accumulate with price target $11 by Global Hunter Securities

Posted on: Thursday,  May 26, 2011  8:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Accumulate Arqule, Inc. (NASDAQ: ARQL) on 05/26/2011, when the stock price was $6.68. Since
then, Arqule, Inc. has lost 73.65% as of 01/22/2016's recent price of $1.76.
If you would have followed this Global Hunter Securities's recommendation on ARQL, you would have lost 73.65% of your investment in 1702 days.

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/26/2011 8:25 AM Buy
None
6.68 11.00
as of 12/30/2011
1 Week down  -0.52 %
1 Month up  0.53 %
3 Months up  11.68 %
1 YTD down  -15.56 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy